Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve With respect to the above cited subject, this is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Wednesday, the 14th of February, 2024 to consider and approve the following: 1. To consider and approve the Un Audited Financial Results of the Company for the Third Quarter ended 31st December, 2023. 2. Other Corporate matters. In furtherance to our previous intimation with respect to Closure of trading window, this is to inform you that the Trading window of the Company for all the designated persons and their immediate relatives will remain closed till 48 hours from the conclusion of the Board meeting. This is for your information and records. Thanking you